Systemic AA Amyloidosis Inhibitors

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$264,984.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AR049166-01A2
Agency Tracking Number:
AR049166
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
PROTEOTECH, INC.
12026 115TH AVE N.E., KIRKLAND, WA, 98034
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
ALAN Snow
(425) 823-6364
SNOW@PROTEOTECH.COM
Business Contact:
DENNIS MCCURLEY
(425) 823-0400
MCCURLEY@PROTEOTECH.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): Systemic AA amyloidosis is characterized by the deposition and accumulation of insoluble fibrillar deposits containing the AA amyloid protein in a number of different organs (including heart, kidney, spleen, lungs

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government